Overexpression of the novel human gene, UBE2Q2, in breast cancer

Cancer Genetics and Cytogenetics

Volumn 197, Issue 2, 2010, Pages 101-106

  Nikseresht, Mohsen ^a   Seghatoleslam, Atefeh ^a   Monabati, Ahmad ^a,b   Talei, Abdolrassul ^a   Ghalati, Farzaneh Bozorg ^a   Owji, Ali Akbar ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; MESSENGER RNA; ONCOPROTEIN; PARAFFIN; POLYCLONAL ANTIBODY; PROTEIN UBE2Q2; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CYTOSKELETAL PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; UBIQUITIN-CONJUGATING ENZYMES;

ORYCTOLAGUS CUNICULUS;

EID: 77249128976     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.11.020     Document Type: Article

References (18)

1. Cromer A., Carles A., Millon R., Ganguli G., Chalmel F., Lemaire F., Young J., Dembele D., Thibault C., Muller D., Poch O., Abecassis J., and Wasylyk B. Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene 23 (2004) 2484-2498
2. Lemaire F., Millon R., Young J., Cromer A., Wasylyk C., Schultz I., Muller D., Marchal P., Zhao C., Melle D., Bracco L., Abecassis J., and Wasylyk B. Differential expression profiling of head and neck squamous cell carcinoma (HNSCC). Br J Cancer 89 (2003) 1940-1949
3. Seghatoleslam A., Zambrano A., Millon R., Ganguli G., Argentini M., Cromer A., Abecassis J., and Wasylyk B. Analysis of a novel human gene, LOC92912, over-expressed in hypopharyngeal tumours. Biochem Biophys Res Commun 339 (2006) 422-429
4. Melner M.H., Ducharme N.A., Brash A.R., Winfrey V.P., and Olson G.E. Differential expression of genes in the endometrium at implantation:upregulation of a novel member of the E2 class of ubiquitin-conjugating enzymes. Biol Reprod 70 (2004) 406-414
5. Nandi D., Tahiliani P., Kumar A., and Chandu D. The ubiquitin-proteasome system. J Biosci 31 (2006) 137-155
6. Semple C.A. The comparative proteomics of ubiquitination in mouse. Genome Res 13 (2003) 1389-1394
7. Hershko A. The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle. Cell Death Differ 12 (2005) 1191-1197
8. Vodermaier H.C. APC/C and SCF: controlling each other and the cell cycle. Curr Biol. 14 (2004) R787-R796
9. Schwartz A.L., and Ciechanover A. Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Schwartz AL. Ciechanover A. Annu Rev Pharmacol Toxicol 49 (2009) 73-96
10. Schwartz A.L., and Ciechanover A. The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu Rev Med 50 (1999) 57-74
11. Lipkowitz S. The role of the ubiquitination-proteasome pathway in breast cancer: ubiquitin mediated degradation of growth factor receptors in the pathogenesis and treatment of cancer. Breast Cancer Res 5 (2003) 8-15
12. Ieta K., Ojima E., Tanaka F., Nakamura Y., Haraguchi N., Mimori K., Inoue H., Kuwano H., and Mori M. Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression. Int J Cancer 121 (2007) 33-38
13. Rossi S., and Loda M. The role of the ubiquitination-proteasome pathway in breast cancer: use of mouse models for analyzing ubiquitination processes. Breast Cancer Res 5 (2003) 16-22
14. Loussouarn D., Campion L., Leclair F., Campone M., Charbonnel C., Ricolleau G., Gouraud W., Bataille R., and Jézéquel P. Validation of UBE2C protein as a prognostic marker in node-positive breast cancer. Br J Cancer 101 (2009) 166-173
15. Tedesco D., Zhang J., Trinh L., Lalehzadeh G., Meisner R., Yamaguchi K.D., Ruderman D.L., Dinter H., and Zajchowski D.A. The ubiquitin-conjugating enzyme E2-EPF is overexpressed in primary breast cancer and modulates sensitivity to topoisomerase II inhibition. Neoplasia 9 (2007) 601-613
16. Xu H., Ju D., Jarois T., and Xie Y. Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells. Breast Cancer Res Treat 107 (2008) 267-274
17. Orlowski R.Z., and Dees E.C. The role of the ubiquitination-proteasome pathway in breast cancer: Applying drugs that affect the ubiquitin-proteasome pathway to the therapy of breast cancer. Breast Cancer Res 5 (2003) 1-7
18. Banerjee S., Brooks W.S., and Crawford D.F. Inactivation of the ubiquitin conjugating enzyme UBE2Q2 causes a prophase arrest and enhanced apoptosis in response to microtubule inhibiting agents. Oncogene 26 (2007) 6509-6517